1. Berger MS Berger BA FDA Overview http://www.emedicinehealth.com/fda_overview/article_em.htm 2011
2. Harris G What's Behind an F.D.A. Stamp? 2008 http://www.nytimes.com/2008/09/30/health/policy/30fda.html?_r=2 & adxnnl=1 & adxnnlx=1282766444 - +QZN1bSKTwSlQ54i7CIceQ
3. Institute of Medicine The Future of Drug Safety: Promoting and Protecting the Health of the Public 2006 http://www.iom.edu/Reports/2006/The - Future - of - Drug - Safety - Promoting - and - Protecting - the - Health - of - the - Public.aspx
4. Food and Drug Administration Guidance for Industry Postmarketing Studies and Clinical Trials 2011 http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/UCM 172001.pdf
5. Guidelines for good pharmacoepidemiology practices (GPP);International Society for Pharmacoepidemiology;Pharmacoepidemiol Drug Saf,2008